Quarterly report pursuant to Section 13 or 15(d)

Related Party Note

v3.2.0.727
Related Party Note
6 Months Ended
Jun. 30, 2015
Related Party Transactions [Abstract]  
Related Party Note
13. Related Party Note
  
Related Party Service Agreement
 
On April 3, 2014, the Company entered into a Shared Services Agreement with OPPM in which the parties agreed to share a rented facility as well as costs for certain services, which they individually require for the operation of their respective entities. The Company’s Chairman, President and Chief Executive Officer and the Company’s Executive Vice Chairman, Strategic Development, are both Co-Portfolio Managers and Partners of OPPM. The Company incurred expense of approximately $44,400 and $87,700 under this agreement for the three and six months ended June 30, 2015 and $38,400 for the three and six months ended June 30, 2014, respectively. The agreement can be terminated by either party with thirty days’ notice.
 
Checkpoint Collaboration Agreement with TGTX
 
In connection with the license agreement with Dana-Farber, Checkpoint entered into a collaboration agreement with TGTX to develop and commercialize the Anti-PD-L1 and Anti-GITR antibody research programs in the field of hematological malignancies. In connection with this Agreement TGTX paid an upfront fee of $0.5 million during the six months ended June 30, 2015 (see Note 1).
 
CB Pharma Acquisition Corp.
 
The receivable from CB Pharma Acquisition Corp at June 30, 2015 and December 31, 2014 was $0.1 million and nil, respectively.